K Nagafuji
Overview
Explore the profile of K Nagafuji including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
429
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kodera Y, Yamamoto K, Harada M, Morishima Y, Dohy H, Asano S, et al.
Bone Marrow Transplant
. 2013 Oct;
49(2):195-200.
PMID: 24076552
Severe adverse events (SAE) and late hematological malignancies have been reported after PBSC donation. No prospective data on incidence and risk factors have been available for family donors so far....
2.
Koyama M, Hashimoto D, Nagafuji K, Eto T, Ohno Y, Aoyama K, et al.
Bone Marrow Transplant
. 2013 Sep;
49(1):110-5.
PMID: 24013691
Graft rejection remains a major obstacle in allogeneic hematopoietic SCT following reduced-intensity conditioning (RIC-SCT), particularly after cord blood transplantation (CBT). In a murine MHC-mismatched model of RIC-SCT, primary graft rejection...
3.
Kim S, Yoon S, Suzuki R, Matsuno Y, Yi H, Yoshida T, et al.
Leukemia
. 2012 Nov;
27(6):1394-7.
PMID: 23183430
No abstract available.
4.
Yanada M, Kurosawa S, Yamaguchi T, Uchida N, Miyawaki S, Kanamori H, et al.
Bone Marrow Transplant
. 2012 Sep;
48(3):390-5.
PMID: 22941379
Although allogeneic hematopoietic cell transplantation (HCT) from a related donor is effective therapy for younger patients with AML, it remains unknown how the availability of a related donor affects the...
5.
Mori Y, Teshima T, Kamezaki K, Kato K, Takenaka K, Iwasaki H, et al.
Bone Marrow Transplant
. 2011 Nov;
47(8):1075-81.
PMID: 22101199
The Pretransplantation Assessment of Mortality (PAM) score is a risk score for mortality after allogeneic hematopoietic SCT (HSCT). Ethnicity is a genetically determined factor that correlated with immune-mediated outcomes of...
6.
Kamimura T, Miyamoto T, Nagafuji K, Numata A, Henzan H, Takase K, et al.
Bone Marrow Transplant
. 2010 Sep;
46(6):820-6.
PMID: 20818443
We retrospectively analyzed the outcomes of 26 patients with acute promyelocytic leukemia (APL) in the first CR (CR1) or second CR (CR2), who underwent autologous PBSCT (auto-PBSCT) between 1992 and...
7.
Aoki T, Kamezaki K, Miyamoto T, Nagafuji K, Mori Y, Yamauchi T, et al.
Transpl Infect Dis
. 2010 Feb;
12(3):277-9.
PMID: 20180927
No abstract available.
8.
Numata A, Miyamoto T, Ohno Y, Kamimura T, Kamezaki K, Tanimoto T, et al.
Bone Marrow Transplant
. 2009 Jul;
45(2):311-6.
PMID: 19597416
Peripheral T-cell lymphoma (PTCL) is generally characterized by poor prognosis after conventional chemotherapy compared with aggressive B-cell lymphoma. To elucidate the role of high-dose chemotherapy (HDCT) with auto-SCT, we retrospectively...
9.
Kohno K, Nagafuji K, Tsukamoto H, Horiuchi T, Takase K, Aoki K, et al.
Transpl Infect Dis
. 2009 May;
11(4):318-23.
PMID: 19453993
Long-term analysis of infectious complication after high-dose immunosuppressive therapy with CD34-selected autologous hematopoietic stem cell transplantation for patients with severe autoimmune diseases (AD) was performed. Theoretically, CD34 selection can reduce...
10.
Shima T, Yoshimoto G, Miyamoto T, Yoshida S, Kamezaki K, Takenaka K, et al.
Transpl Infect Dis
. 2008 Nov;
11(1):75-7.
PMID: 19000153
Here we report the case of a 43-year-old Japanese woman with acute myelogenous leukemia who underwent 2 unrelated cord blood transplantations (UCBT), terminating in fatal disseminated tuberculosis (TB). The patient...